sur Volta Medical SAS
Volta Medical will present innovative results in cardiac electrophysiology
The company Volta Medical SAS, specializing in the development of artificial intelligence solutions for rhythmic cardiologists, announced that it will present the conclusions of its TAILORED-AF study during the Late-Breaking sessions of the Heart Rhythm 2024 congress. will take place from May 16 to 19 in Boston, United States, with participation possible both online and in person.
The major presentation will focus on data from the TAILORED-AF randomized clinical trial, led by Professor Isabel Deisenhofer of the German Cardiology Center in Munich. This study examined an innovative AI-assisted cardiac ablation approach for the treatment of persistent atrial fibrillation. The multicenter trial included 26 centers across five countries.
In addition, Volta Medical will present AF-Xplorer™, a medical device that can identify atypical electrograms during ablation procedures. The conference will also include expert discussions and presentations on the future of artificial intelligence in cardiovascular medical procedures.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Volta Medical SAS